11-hydroxyandrostenedione has been researched along with Adenoma, Prostatic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Imperato-McGinley, J; Orlic, S; Shackleton, C; Stoner, E | 1 |
1 trial(s) available for 11-hydroxyandrostenedione and Adenoma, Prostatic
| Article | Year |
|---|---|
C19 and C21 5 beta/5 alpha metabolite ratios in subjects treated with the 5 alpha-reductase inhibitor finasteride: comparison of male pseudohermaphrodites with inherited 5 alpha-reductase deficiency.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Aged; Androstenedione; Androstenes; Androsterone; Azasteroids; Corticosterone; Dihydrotestosterone; Disorders of Sex Development; Etiocholanolone; Finasteride; Gas Chromatography-Mass Spectrometry; Humans; Hydrocortisone; Liver; Luteinizing Hormone; Male; Middle Aged; Prostatic Hyperplasia; Radioimmunoassay; Randomized Controlled Trials as Topic; Steroids, Heterocyclic; Testosterone | 1990 |